Fosphenytoin Sodium Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg
Reference Brands: Cerebyx (USA)
Category:
Neurology
Fosphenytoin sodium is available in Injection
and strengths such as 50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fosphenytoin sodium is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fosphenytoin sodium can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fosphenytoin sodium is a water-soluble phosphate ester prodrug of phenytoin developed for intravenous and intramuscular administration. It is rapidly converted to phenytoin in the body and is used in the acute management of seizure disorders, particularly convulsive status epilepticus. Compared to intravenous phenytoin, fosphenytoin offers improved safety and tolerability, with a reduced risk of local tissue injury and cardiovascular complications.
In the United States, fosphenytoin sodium is approved for short-term use, typically for five days or fewer, in the treatment of epilepsy when oral or standard phenytoin administration is not feasible or is contraindicated. This includes clinical situations such as status epilepticus, repeated or cluster seizures, endotracheal intubation, persistent vomiting, or cases where the patient is unresponsive or unable to swallow.
Due to its rapid onset of action and flexible administration routes, fosphenytoin sodium is widely utilized in emergency and critical care settings. Its predictable conversion to phenytoin allows effective seizure control while providing enhanced safety during acute neurological emergencies.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing